| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.10B | +46.9% |
| Gross Profit | $909.6M | +49.0% |
| R&D Expense | $205.2M | +71.4% |
| SG&A Expense | $123.2M | +33.3% |
| Operating Income | $175.8M | +55.2% |
| Interest Expense | $47.6M | +8.4% |
| Pre-tax Income | $194.6M | +92.7% |
| Income Tax | $131.4M | +2054.1% |
| Net Income | $63.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $418.0M | +35.6% |
| Short-term Investments | $127.7M | +594.0% |
| Accounts Receivable | $222.9M | +19.2% |
| Current Assets | $832.0M | +52.5% |
| Total Assets | $7.14B | +4.1% |
| Current Liabilities | $572.7M | +12.8% |
| Long-term Debt | $1.24B | +0.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $417.0M | +39.3% |
| Investing Cash Flow | -$281.1M | +59.6% |
| Financing Cash Flow | -$25.9M | -105.9% |
| -45.9% |
| EPS (Basic) | $0.16 | -65.2% |
| EPS (Diluted) | $0.16 | -62.8% |
| Total Liabilities |
| $4.86B |
| +0.2% |
| Stockholders' Equity | $2.27B | +13.7% |